Katalyze AI today announced the launch of Katalyst, an AI agent purpose-built for pharmaceutical manufacturing. Designed for GxP-regulated environments, Katalyst helps manufacturing teams reduce ...

This week's report explores the pharmaceutical industry’s evolution toward resilient, scalable systems that prioritize ...

SAN FRANCISCO--(BUSINESS WIRE)--Multiply Labs, a robotics company developing industry-leading automated manufacturing systems to produce individualized drugs, and GenScript Biotech Corporation ...

USP is developing digital reference standards to integrate into modern digital environments, enhancing regulatory confidence ...

Technological innovations throughout the past several decades have transformed the pharmaceutical manufacturing process from traditional batch production to ...

RICHMOND, Va., January 14, 2026 – Phlow Corp., a leading American pharmaceutical contract development and manufacturing organization (CDMO), today announced a major advancement in AI-driven Active ...

Given the complexity of alternative-protein manufacturing, many biotech companies are exploring how to reduce costs with AI technologies, process improvements and novel uses for waste streams from ...

Operating under the FDA's 503B pathway, the Apex facility will prioritize the production of generic shortage-listed ...

Being Proactive Instead of Passive Is the Cornerstone of Process Analytical Technology Interest in the application of process analytical technology (PAT) to pharma and biotech stems from the ...

DUBLIN, Ireland, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including ...

DUBLIN, Ireland, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, ...